Robert Axtell to Mice, Transgenic
This is a "connection" page, showing publications Robert Axtell has written about Mice, Transgenic.
Connection Strength
0.326
-
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
Score: 0.109
-
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol. 2006 Dec 15; 177(12):8542-9.
Score: 0.062
-
Immunization-Expanded NKT Follicular Helper Cells Drive IgG1 Isotype Switch against an Exogenous T-Independent Polysaccharide but Do Not Promote Recall Responses. Immunohorizons. 2019 03; 3(3):88-93.
Score: 0.036
-
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017 12 15; 313:77-81.
Score: 0.033
-
Astrocytic TGF-ß signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J Immunol. 2014 Jul 01; 193(1):139-49.
Score: 0.026
-
CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J Immunol. 2012 Sep 15; 189(6):2918-30.
Score: 0.023
-
Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010 Feb 09; 107(6):2580-5.
Score: 0.019
-
Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2008 Jul 01; 181(1):338-45.
Score: 0.017